Sweden-based Pergamum has dosed the first patient in a randomised Phase II study of DPK-060, designed for the treatment of patients with external otitis (swimmers ear).

DPK-060 is a novel anti-microbial peptide that has a broad spectrum action on bacteria including Staphylococcus aureus, multidrug resistant strains, Candida and Malassezia. The double-blind randomised placebo-controlled multicentre Phase II trial will enroll up to 70 patients with acute external otitis is intended to evaluate the efficacy, local tolerability and safety of DPK-060 ear drops in infections caused by bacterial or fungal pathogens.

Pergamum CEO Jonas Ekblom said DPK-060 is thought to have a positive impact in treating patients with external otitis. "Every year more than ten million people world-wide seek medical care for treatment of infections in the outer ear. There is a significant medical need to avoid rapidly increasing global prevalence of antibiotics resistance that limits the therapeutic value of conventional products,” he said.

Pergamum chairman of the board Torbjörn Bjerke said the company has developed a new class of broad-spectrum acting antimicrobial agents based on a peptide from the body’s own defence system. "The results of this clinical study is an important step towards a potential new prescription product for topical application that could change the treatment of skin infections, not only in the field of external otitis, but also in several other infections under investigation by Pergamum," he added.

DPK-060 has shown positive data in a Phase II study in atopic dermatitis patients and has demonstrated the ability to treat many other dermatological conditions caused by the microorganisms. An earlier Phase I/II study also reported that DPK-060 successfully met primary the endpoint in treating skin infections.

Pergamum is a clinical-stage biopharmaceutical company, focused on developing state-of-the-art products, based on therapeutic peptides, for local application in dermatology, wound healing and anti-infection.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.